Innovation drug concept repeatedly active, shares of companies like Merck have hit the daily limit rise.

The concept of innovative drugs is repeatedly active, Meenuohua has had 6 trading limits in the past 7 days, Wanbangde, Shuanglu Pharmaceutical, and Dongcheng Pharmaceutical have all reached their trading limits, while Lianhuan Pharmaceutical, Hait Pharmaceutical, Shuteishen, and Hong Bo Pharmaceutical are all following up with gains. On the news front, Lilly and Insilico Medicine have reached a $2.75 billion agreement to push the latter's AI-developed drugs to the global market. According to the announcement, this agreement will provide Insilico Medicine with a $115 million upfront payment, with the remaining payments based on regulatory and commercial milestones as well as future sales royalties.